Skip to main content
. 2018 Feb 7;149(3):253–261. doi: 10.1093/ajcp/aqx162

Image 1.

Image 1

An inflammatory breast cancer (IBC) sample with negative programmed death ligand 1 (PD-L1) expression (A) and another IBC sample showing PD-L1 expression in approximately 40% of tumor cells (B) (×400).